Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets. Alnoumas L, van den Driest L, Apczynski Z, Lannigan A, et al. BMC Cancer 2022;22:874.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alnoumas L, van den Driest L, Apczynski Z, Lannigan A, et al. Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets. BMC Cancer 2022;22:874.
PMID: 35948941